| 1 | VTRS | Viatris Inc. | 2.55% |
| 2 | MBX | MBX Biosciences, Inc. | 2.47% |
| 3 | DFTX | Definium Therapeutics, Inc. | 2.46% |
| 4 | EWTX | Edgewise Therapeutics, Inc. | 2.40% |
| 5 | NKTR | Nektar Therapeutics | 2.31% |
| 6 | AXSM | Axsome Therapeutics, Inc. | 2.30% |
| 7 | MRK | Merck & Co., Inc. | 2.29% |
| 8 | AMRX | Amneal Pharmaceuticals, Inc. | 2.25% |
| 9 | LQDA | Liquidia Corporation | 2.24% |
| 10 | PAHC | Phibro Animal Health Corporation | 2.24% |
| 11 | JNJ | Johnson & Johnson | 2.22% |
| 12 | RPRX | Royalty Pharma plc | 2.20% |
| 13 | BMY | Bristol-Myers Squibb Company | 2.19% |
| 14 | ELAN | Elanco Animal Health Incorporated | 2.18% |
| 15 | PBH | Prestige Consumer Healthcare Inc. | 2.05% |
| 16 | INVA | Innoviva, Inc. | 2.04% |
| 17 | SUPN | Supernus Pharmaceuticals, Inc. | 2.02% |
| 18 | PFE | Pfizer Inc. | 2.00% |
| 19 | ZTS | Zoetis Inc. | 1.99% |
| 20 | PRGO | Perrigo Company plc | 1.99% |
| 21 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.99% |
| 22 | MAZE | Maze Therapeutics, Inc. | 1.98% |
| 23 | LLY | Eli Lilly and Company | 1.96% |
| 24 | ELVN | Enliven Therapeutics, Inc. | 1.92% |
| 25 | JAZZ | Jazz Pharmaceuticals plc | 1.89% |
| View XPH holdings |